The first tau PET imaging results in the AD spectrum have provided compelling evidence for a tight relationship between tau burden and synaptic dysfunction, gray matter atrophy, and cognitive deficits117–120, confirming previous post-mortem evidence121,122. This evidence concerns the gene MAPT and Alzheimer disease.